#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glioblastoma multiforme Glomerulonephritis minimal lesion Gastrooesophageal cancer Vulval cancer Neutropenia Fusarium infection Glomerulonephritis membranoproliferative Medullary thyroid cancer Acute lymphocytic leukaemia recurrent Epstein-Barr virus associated lymphoproliferative disorder Univentricular heart Niemann-Pick disease Acute myeloid leukaemia recurrent Squamous cell carcinoma of the hypopharynx Breast angiosarcoma metastatic More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease Soft tissue sarcoma – Life with Disease Angiosarcoma non-metastatic – Basic Information Urea cycle disorder – Basic Information Kearns-Sayre syndrome – Trials in Disease Hepatoblastoma Atypical haemolytic uraemic syndrome – Trials in Disease Urea cycle disorder – Trials in Disease Extranodal marginal zone B-cell lymphoma (MALT type) Primary hyperoxaluria – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fazirsiran Brodalumab Budesonide Donepezil H2-Receptor Antagonists Polydextrose Emavusertib Quinidine Sulfate Insulin Icodec Rbd4059 Imiglucerase Mannitol ALXN2420 ARGININE GLUTAMATE Mitomycin Paracetamol Ph. Eur. Levamisole Hydrochloride VRDN-003 LTX-002 SODIUM Chlorhexidine Gluconate More therapies…

    Learn about Your Condition

    Neuralgia Stress urinary incontinence Fatty acid oxidation disorder Apathy Hepatocellular carcinoma Rett syndrome Cholecystitis acute Spermatocele Systemic infection Vaginal infection Mantle cell lymphoma recurrent Urticaria chronic Hip arthroplasty Exudative retinopathy Breast proliferative changes More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Genetic Phenomena

  • Evaluation of D-Glucose-13C6 Test for Detecting SDHx Mutations in Patients with Pheochromocytoma or Paraganglioma

    Not yet recruiting

    2 1 1
    France

  • Autologous CD4+ T-Cell Gene Therapy for X-linked Hyper-IgM Syndrome Type 1 in Patients with X-linked Hyper-IgM Syndrome Type 1

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Primary immunodeficiency syndrome
    Investigated Drugs:
    • HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE
    • HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA]
    Italy

  • A Study Testing VX-407 in Patients with Autosomal Dominant Polycystic Kidney Disease Who Have Specific PKD1 Gene Changes

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • VX-407
    Belgium France Germany Italy The Netherlands Spain

  • Study on Perampanel for Improving Behavior and Quality of Life in Patients with White-Sutton Syndrome

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Perampanel
    Italy

  • Study on the Effect and Safety of Autologous Mesoangioblasts for Patients with Mitochondrial Myopathy Due to m.3243A>G Mutation

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Autologous Muscle Precursor Cells
    The Netherlands

  • Study on Gene Therapy with Autologous Stem Cells and Drug Combination for Children with Mucopolysaccharidosis Type I Hurler Variant

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Autologous Cd34+ Haematopoietic Stem And Progenitor Cells Genetically Modified With The Lentiviral Vector Idua Lv, Encoding For The Alpha-L-Iduronidase Cdna
    • Lenograstim
    • Plerixafor
    Italy
Previous Page
1 2 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!